nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine triphosphate—ALK—peripheral nervous system neoplasm	0.328	0.522	CbGaD
Adenosine triphosphate—AKT1—peripheral nervous system neoplasm	0.256	0.407	CbGaD
Adenosine triphosphate—ABCB1—peripheral nervous system neoplasm	0.0448	0.0711	CbGaD
Adenosine triphosphate—ABCB11—Vincristine—peripheral nervous system neoplasm	0.034	0.195	CbGbCtD
Adenosine triphosphate—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.0213	0.122	CbGbCtD
Adenosine triphosphate—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0179	0.103	CbGbCtD
Adenosine triphosphate—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0167	0.0956	CbGbCtD
Adenosine triphosphate—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0164	0.0939	CbGbCtD
Adenosine triphosphate—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0137	0.0783	CbGbCtD
Adenosine triphosphate—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0137	0.0783	CbGbCtD
Adenosine triphosphate—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0112	0.0641	CbGbCtD
Adenosine triphosphate—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00947	0.0543	CbGbCtD
Adenosine triphosphate—ACVR1—pes—peripheral nervous system neoplasm	0.00649	0.107	CbGeAlD
Adenosine triphosphate—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00583	0.0334	CbGbCtD
Adenosine triphosphate—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00544	0.0312	CbGbCtD
Adenosine triphosphate—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00534	0.0306	CbGbCtD
Adenosine triphosphate—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00364	0.0209	CbGbCtD
Adenosine triphosphate—Tenofovir—NME1—peripheral nervous system neoplasm	0.00323	1	CrCbGaD
Adenosine triphosphate—AKT1—forelimb—peripheral nervous system neoplasm	0.00276	0.0455	CbGeAlD
Adenosine triphosphate—ACSS1—tongue—peripheral nervous system neoplasm	0.00179	0.0296	CbGeAlD
Adenosine triphosphate—ACSS2—tongue—peripheral nervous system neoplasm	0.00172	0.0284	CbGeAlD
Adenosine triphosphate—AKT1—nerve—peripheral nervous system neoplasm	0.00151	0.0249	CbGeAlD
Adenosine triphosphate—AKT1—ganglion—peripheral nervous system neoplasm	0.00149	0.0246	CbGeAlD
Adenosine triphosphate—ABCG1—trigeminal ganglion—peripheral nervous system neoplasm	0.00137	0.0225	CbGeAlD
Adenosine triphosphate—HSPA1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00127	0.021	CbGeAlD
Adenosine triphosphate—HSPA1A—trigeminal ganglion—peripheral nervous system neoplasm	0.00127	0.021	CbGeAlD
Adenosine triphosphate—HSPA1B—parotid gland—peripheral nervous system neoplasm	0.0012	0.0198	CbGeAlD
Adenosine triphosphate—HSPA1A—parotid gland—peripheral nervous system neoplasm	0.0012	0.0198	CbGeAlD
Adenosine triphosphate—ARAF—trigeminal ganglion—peripheral nervous system neoplasm	0.00119	0.0197	CbGeAlD
Adenosine triphosphate—ADCY1—brainstem—peripheral nervous system neoplasm	0.00117	0.0193	CbGeAlD
Adenosine triphosphate—ASNA1—trigeminal ganglion—peripheral nervous system neoplasm	0.00112	0.0185	CbGeAlD
Adenosine triphosphate—AFG3L2—trigeminal ganglion—peripheral nervous system neoplasm	0.0011	0.0182	CbGeAlD
Adenosine triphosphate—NAE1—trigeminal ganglion—peripheral nervous system neoplasm	0.00108	0.0178	CbGeAlD
Adenosine triphosphate—ASNA1—parotid gland—peripheral nervous system neoplasm	0.00105	0.0174	CbGeAlD
Adenosine triphosphate—NAE1—parotid gland—peripheral nervous system neoplasm	0.00102	0.0168	CbGeAlD
Adenosine triphosphate—ASNA1—brainstem—peripheral nervous system neoplasm	0.00099	0.0163	CbGeAlD
Adenosine triphosphate—AFG3L2—brainstem—peripheral nervous system neoplasm	0.000977	0.0161	CbGeAlD
Adenosine triphosphate—NAE1—brainstem—peripheral nervous system neoplasm	0.000953	0.0157	CbGeAlD
Adenosine triphosphate—APAF1—cerebellum—peripheral nervous system neoplasm	0.000935	0.0154	CbGeAlD
Adenosine triphosphate—ACSS1—trigeminal ganglion—peripheral nervous system neoplasm	0.00089	0.0147	CbGeAlD
Adenosine triphosphate—ACVR1—trigeminal ganglion—peripheral nervous system neoplasm	0.000871	0.0144	CbGeAlD
Adenosine triphosphate—ACSS2—trigeminal ganglion—peripheral nervous system neoplasm	0.000853	0.0141	CbGeAlD
Adenosine triphosphate—ACSL1—trigeminal ganglion—peripheral nervous system neoplasm	0.000848	0.014	CbGeAlD
Adenosine triphosphate—ACSS1—parotid gland—peripheral nervous system neoplasm	0.000839	0.0138	CbGeAlD
Adenosine triphosphate—NT5C2—parotid gland—peripheral nervous system neoplasm	0.000821	0.0136	CbGeAlD
Adenosine triphosphate—ACVR1—parotid gland—peripheral nervous system neoplasm	0.000821	0.0136	CbGeAlD
Adenosine triphosphate—ACSS2—parotid gland—peripheral nervous system neoplasm	0.000805	0.0133	CbGeAlD
Adenosine triphosphate—ACSL1—parotid gland—peripheral nervous system neoplasm	0.000799	0.0132	CbGeAlD
Adenosine triphosphate—AKT1—trigeminal ganglion—peripheral nervous system neoplasm	0.000732	0.0121	CbGeAlD
Adenosine triphosphate—ASNS—trigeminal ganglion—peripheral nervous system neoplasm	0.000732	0.0121	CbGeAlD
Adenosine triphosphate—AKT1—parotid gland—peripheral nervous system neoplasm	0.00069	0.0114	CbGeAlD
Adenosine triphosphate—ASNS—parotid gland—peripheral nervous system neoplasm	0.00069	0.0114	CbGeAlD
Adenosine triphosphate—ADRBK2—cerebellum—peripheral nervous system neoplasm	0.000657	0.0108	CbGeAlD
Adenosine triphosphate—AKT1—brainstem—peripheral nervous system neoplasm	0.000648	0.0107	CbGeAlD
Adenosine triphosphate—ASS1—trigeminal ganglion—peripheral nervous system neoplasm	0.000638	0.0105	CbGeAlD
Adenosine triphosphate—ASS1—parotid gland—peripheral nervous system neoplasm	0.000602	0.00993	CbGeAlD
Adenosine triphosphate—ABCG1—cerebellum—peripheral nervous system neoplasm	0.000596	0.00983	CbGeAlD
Adenosine triphosphate—ACVRL1—cerebellum—peripheral nervous system neoplasm	0.000596	0.00983	CbGeAlD
Adenosine triphosphate—ADCY1—cerebellum—peripheral nervous system neoplasm	0.000578	0.00953	CbGeAlD
Adenosine triphosphate—ADK—trigeminal ganglion—peripheral nervous system neoplasm	0.000557	0.0092	CbGeAlD
Adenosine triphosphate—HSPA1B—cerebellum—peripheral nervous system neoplasm	0.000556	0.00918	CbGeAlD
Adenosine triphosphate—HSPA1A—cerebellum—peripheral nervous system neoplasm	0.000556	0.00918	CbGeAlD
Adenosine triphosphate—ADK—parotid gland—peripheral nervous system neoplasm	0.000526	0.00867	CbGeAlD
Adenosine triphosphate—ARAF—cerebellum—peripheral nervous system neoplasm	0.00052	0.00858	CbGeAlD
Adenosine triphosphate—ACVR1B—cerebellum—peripheral nervous system neoplasm	0.000505	0.00833	CbGeAlD
Adenosine triphosphate—ASNA1—cerebellum—peripheral nervous system neoplasm	0.000488	0.00805	CbGeAlD
Adenosine triphosphate—AFG3L2—cerebellum—peripheral nervous system neoplasm	0.000482	0.00795	CbGeAlD
Adenosine triphosphate—NAE1—cerebellum—peripheral nervous system neoplasm	0.00047	0.00775	CbGeAlD
Adenosine triphosphate—ABCC8—brainstem—peripheral nervous system neoplasm	0.000457	0.00755	CbGeAlD
Adenosine triphosphate—SLC25A4—cerebellum—peripheral nervous system neoplasm	0.000438	0.00722	CbGeAlD
Adenosine triphosphate—TNK2—cerebellum—peripheral nervous system neoplasm	0.000429	0.00708	CbGeAlD
Adenosine triphosphate—ABL1—trigeminal ganglion—peripheral nervous system neoplasm	0.000401	0.00662	CbGeAlD
Adenosine triphosphate—ADRBK1—cerebellum—peripheral nervous system neoplasm	0.000388	0.00641	CbGeAlD
Adenosine triphosphate—ACSS1—cerebellum—peripheral nervous system neoplasm	0.000388	0.00641	CbGeAlD
Adenosine triphosphate—ABCA1—cerebellum—peripheral nervous system neoplasm	0.000384	0.00634	CbGeAlD
Adenosine triphosphate—NT5C2—cerebellum—peripheral nervous system neoplasm	0.00038	0.00627	CbGeAlD
Adenosine triphosphate—ACVR1—cerebellum—peripheral nervous system neoplasm	0.00038	0.00627	CbGeAlD
Adenosine triphosphate—ABL1—parotid gland—peripheral nervous system neoplasm	0.000378	0.00624	CbGeAlD
Adenosine triphosphate—ACSS2—cerebellum—peripheral nervous system neoplasm	0.000372	0.00614	CbGeAlD
Adenosine triphosphate—ACSL1—cerebellum—peripheral nervous system neoplasm	0.00037	0.0061	CbGeAlD
Adenosine triphosphate—ABL2—cerebellum—peripheral nervous system neoplasm	0.000363	0.00599	CbGeAlD
Adenosine triphosphate—ABL1—brainstem—peripheral nervous system neoplasm	0.000355	0.00586	CbGeAlD
Adenosine triphosphate—PRKAA1—cerebellum—peripheral nervous system neoplasm	0.00035	0.00577	CbGeAlD
Adenosine triphosphate—AKT1—cerebellum—peripheral nervous system neoplasm	0.000319	0.00527	CbGeAlD
Adenosine triphosphate—ASNS—cerebellum—peripheral nervous system neoplasm	0.000319	0.00527	CbGeAlD
Adenosine triphosphate—SLC25A4—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.000301	0.0592	CbGdCrCtD
Adenosine triphosphate—SLC25A4—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.000301	0.0592	CbGdCrCtD
Adenosine triphosphate—ASS1—cerebellum—peripheral nervous system neoplasm	0.000278	0.00459	CbGeAlD
Adenosine triphosphate—ADK—cerebellum—peripheral nervous system neoplasm	0.000243	0.00401	CbGeAlD
Adenosine triphosphate—SLC25A4—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.000228	0.0448	CbGdCrCtD
Adenosine triphosphate—ABCC8—cerebellum—peripheral nervous system neoplasm	0.000226	0.00372	CbGeAlD
Adenosine triphosphate—HSPA1A—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000224	0.044	CbGdCrCtD
Adenosine triphosphate—AKT1—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00022	0.0431	CbGdCrCtD
Adenosine triphosphate—AKT1—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.00022	0.0431	CbGdCrCtD
Adenosine triphosphate—AKT1—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.00022	0.0431	CbGdCrCtD
Adenosine triphosphate—AKT1—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00022	0.0431	CbGdCrCtD
Adenosine triphosphate—SLC25A4—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00021	0.0414	CbGdCrCtD
Adenosine triphosphate—SLC25A4—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.00021	0.0414	CbGdCrCtD
Adenosine triphosphate—SLC25A4—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.00021	0.0414	CbGdCrCtD
Adenosine triphosphate—SLC25A4—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00021	0.0414	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000187	0.0367	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000187	0.0367	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000187	0.0367	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000187	0.0367	CbGdCrCtD
Adenosine triphosphate—ABL1—cerebellum—peripheral nervous system neoplasm	0.000175	0.00289	CbGeAlD
Adenosine triphosphate—AKT1—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.0327	CbGdCrCtD
Adenosine triphosphate—AKT1—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.0327	CbGdCrCtD
Adenosine triphosphate—SLC25A4—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.00016	0.0313	CbGdCrCtD
Adenosine triphosphate—SLC25A4—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.00016	0.0313	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.0278	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.0278	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Vindesine—Vincristine—peripheral nervous system neoplasm	0.000133	0.0261	CbGdCrCtD
Adenosine triphosphate—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000125	0.00206	CbGeAlD
Adenosine triphosphate—HSPA1A—Podofilox—Etoposide—peripheral nervous system neoplasm	8.39e-05	0.0165	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Vinblastine—Vincristine—peripheral nervous system neoplasm	5.77e-05	0.0113	CbGdCrCtD
Adenosine triphosphate—ABCB1—cerebellum—peripheral nervous system neoplasm	5.44e-05	0.000898	CbGeAlD
Adenosine triphosphate—HSPA1A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.00859	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.00859	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.00795	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.00795	CbGdCrCtD
Adenosine triphosphate—ABL1—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.00651	CbGdCrCtD
Adenosine triphosphate—ABL1—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.00651	CbGdCrCtD
Adenosine triphosphate—ABL1—Idarubicin—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.00651	CbGdCrCtD
Adenosine triphosphate—ABL1—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.00603	CbGdCrCtD
Adenosine triphosphate—ABL1—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.00603	CbGdCrCtD
Adenosine triphosphate—ABL1—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.00603	CbGdCrCtD
Adenosine triphosphate—AKT1—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	1.48e-05	0.000117	CbGpPWpGaD
Adenosine triphosphate—AKT1—DAP12 signaling—HRAS—peripheral nervous system neoplasm	1.48e-05	0.000116	CbGpPWpGaD
Adenosine triphosphate—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.48e-05	0.000116	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.47e-05	0.000116	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—ENO2—peripheral nervous system neoplasm	1.46e-05	0.000115	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—ERBB2—peripheral nervous system neoplasm	1.46e-05	0.000115	CbGpPWpGaD
Adenosine triphosphate—AKT1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	1.46e-05	0.000115	CbGpPWpGaD
Adenosine triphosphate—AKT1—RNF mutants show enhanced WNT signaling and proliferation—MYC—peripheral nervous system neoplasm	1.45e-05	0.000114	CbGpPWpGaD
Adenosine triphosphate—ABL2—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.45e-05	0.000114	CbGpPWpGaD
Adenosine triphosphate—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.45e-05	0.000114	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.43e-05	0.000113	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—MET—peripheral nervous system neoplasm	1.42e-05	0.000112	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.42e-05	0.000112	CbGpPWpGaD
Adenosine triphosphate—ABL1—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	1.41e-05	0.000111	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—TH—peripheral nervous system neoplasm	1.41e-05	0.000111	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.41e-05	0.000111	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	1.4e-05	0.00011	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Neuronal System—HRAS—peripheral nervous system neoplasm	1.4e-05	0.00011	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	1.39e-05	0.000109	CbGpPWpGaD
Adenosine triphosphate—AKT1—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	1.39e-05	0.000109	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	1.39e-05	0.000109	CbGpPWpGaD
Adenosine triphosphate—AKT1—DAP12 interactions—HRAS—peripheral nervous system neoplasm	1.39e-05	0.000109	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by NGF—AKT1—peripheral nervous system neoplasm	1.38e-05	0.000109	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	1.38e-05	0.000108	CbGpPWpGaD
Adenosine triphosphate—AKT1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.37e-05	0.000108	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.37e-05	0.000107	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	1.37e-05	0.000107	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.36e-05	0.000107	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.36e-05	0.000107	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	1.36e-05	0.000107	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by WNT in cancer—MYC—peripheral nervous system neoplasm	1.35e-05	0.000106	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Gene Expression—MYC—peripheral nervous system neoplasm	1.35e-05	0.000106	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—NRAS—peripheral nervous system neoplasm	1.34e-05	0.000106	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by NGF—AKT1—peripheral nervous system neoplasm	1.32e-05	0.000104	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.32e-05	0.000104	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	1.32e-05	0.000104	CbGpPWpGaD
Adenosine triphosphate—AKT1—Focal Adhesion—HRAS—peripheral nervous system neoplasm	1.31e-05	0.000103	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.3e-05	0.000102	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.3e-05	0.000102	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—NRAS—peripheral nervous system neoplasm	1.29e-05	0.000102	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.29e-05	0.000102	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.29e-05	0.000102	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.29e-05	0.000101	CbGpPWpGaD
Adenosine triphosphate—AKT1—B Cell Activation—HRAS—peripheral nervous system neoplasm	1.29e-05	0.000101	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.28e-05	0.000101	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IFNB1—peripheral nervous system neoplasm	1.27e-05	9.99e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—GNAS—peripheral nervous system neoplasm	1.26e-05	9.91e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.26e-05	9.88e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—MYC—peripheral nervous system neoplasm	1.25e-05	9.84e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	1.25e-05	9.83e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Gene Expression—MYC—peripheral nervous system neoplasm	1.24e-05	9.78e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.24e-05	9.76e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.24e-05	9.76e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.24e-05	9.75e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—NRAS—peripheral nervous system neoplasm	1.24e-05	9.75e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.24e-05	9.72e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	1.23e-05	9.69e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—PTPN11—peripheral nervous system neoplasm	1.23e-05	9.66e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—ENO2—peripheral nervous system neoplasm	1.23e-05	9.66e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.22e-05	9.59e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.2e-05	9.48e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IFNB1—peripheral nervous system neoplasm	1.2e-05	9.47e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.2e-05	9.42e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.19e-05	9.38e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	1.19e-05	9.33e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.18e-05	9.32e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—SLC2A1—peripheral nervous system neoplasm	1.18e-05	9.29e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—PTPN11—peripheral nervous system neoplasm	1.18e-05	9.29e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	1.18e-05	9.28e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.17e-05	9.19e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—PTPN11—peripheral nervous system neoplasm	1.16e-05	9.16e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—NRAS—peripheral nervous system neoplasm	1.16e-05	9.12e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—MYC—peripheral nervous system neoplasm	1.15e-05	9.08e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—GNAS—peripheral nervous system neoplasm	1.15e-05	9.06e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.15e-05	9.03e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.15e-05	9.01e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—PTPN11—peripheral nervous system neoplasm	1.13e-05	8.91e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.13e-05	8.91e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—ABCB1—peripheral nervous system neoplasm	1.13e-05	8.89e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.13e-05	8.86e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	1.11e-05	8.78e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—NRAS—peripheral nervous system neoplasm	1.11e-05	8.74e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by Wnt—MYC—peripheral nervous system neoplasm	1.11e-05	8.74e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.1e-05	8.7e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.1e-05	8.65e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.1e-05	8.64e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.09e-05	8.62e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—PTPN11—peripheral nervous system neoplasm	1.09e-05	8.58e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—MYC—peripheral nervous system neoplasm	1.08e-05	8.49e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.05e-05	8.29e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—PTPN11—peripheral nervous system neoplasm	1.04e-05	8.22e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.04e-05	8.2e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.04e-05	8.18e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—BCHE—peripheral nervous system neoplasm	1.04e-05	8.16e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.89e-06	7.78e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—HRAS—peripheral nervous system neoplasm	9.81e-06	7.73e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HGF—peripheral nervous system neoplasm	9.8e-06	7.72e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—TH—peripheral nervous system neoplasm	9.74e-06	7.67e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—ERBB2—peripheral nervous system neoplasm	9.7e-06	7.64e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.68e-06	7.62e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	9.61e-06	7.56e-05	CbGpPWpGaD
Adenosine triphosphate—ABCG1—Metabolism—AKT1—peripheral nervous system neoplasm	9.58e-06	7.54e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—HRAS—peripheral nervous system neoplasm	9.47e-06	7.45e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Gene Expression—AKT1—peripheral nervous system neoplasm	9.33e-06	7.35e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—ERBB2—peripheral nervous system neoplasm	9.33e-06	7.34e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	9.32e-06	7.33e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HGF—peripheral nervous system neoplasm	9.29e-06	7.31e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—ERBB2—peripheral nervous system neoplasm	9.2e-06	7.24e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	9.1e-06	7.16e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—HRAS—peripheral nervous system neoplasm	9.06e-06	7.13e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—ERBB2—peripheral nervous system neoplasm	8.94e-06	7.04e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	8.93e-06	7.03e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—HRAS—peripheral nervous system neoplasm	8.91e-06	7.02e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.89e-06	7e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	8.72e-06	6.86e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—AKT1—peripheral nervous system neoplasm	8.67e-06	6.82e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.63e-06	6.79e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Gene Expression—AKT1—peripheral nervous system neoplasm	8.61e-06	6.78e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—ERBB2—peripheral nervous system neoplasm	8.61e-06	6.78e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—HRAS—peripheral nervous system neoplasm	8.55e-06	6.73e-05	CbGpPWpGaD
Adenosine triphosphate—NT5C2—Metabolism—AKT1—peripheral nervous system neoplasm	8.54e-06	6.72e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—HRAS—peripheral nervous system neoplasm	8.47e-06	6.67e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—NRAS—peripheral nervous system neoplasm	8.36e-06	6.58e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.28e-06	6.52e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	8.28e-06	6.52e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—ERBB2—peripheral nervous system neoplasm	8.26e-06	6.5e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—NRAS—peripheral nervous system neoplasm	8.2e-06	6.45e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—HRAS—peripheral nervous system neoplasm	8.12e-06	6.39e-05	CbGpPWpGaD
Adenosine triphosphate—ACSS1—Metabolism—AKT1—peripheral nervous system neoplasm	8.02e-06	6.32e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—AKT1—peripheral nervous system neoplasm	8e-06	6.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—GNAS—peripheral nervous system neoplasm	7.96e-06	6.26e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.95e-06	6.26e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	7.94e-06	6.25e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—NRAS—peripheral nervous system neoplasm	7.92e-06	6.24e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—AKT1—peripheral nervous system neoplasm	7.87e-06	6.2e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.83e-06	6.16e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.81e-06	6.15e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—NRAS—peripheral nervous system neoplasm	7.77e-06	6.12e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.77e-06	6.11e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	7.64e-06	6.01e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.63e-06	6.01e-05	CbGpPWpGaD
Adenosine triphosphate—ACSS2—Metabolism—AKT1—peripheral nervous system neoplasm	7.61e-06	5.99e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.61e-06	5.99e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.6e-06	5.98e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—AKT1—peripheral nervous system neoplasm	7.55e-06	5.94e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—AKT1—peripheral nervous system neoplasm	7.48e-06	5.89e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.45e-06	5.86e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—NRAS—peripheral nervous system neoplasm	7.38e-06	5.81e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.32e-06	5.76e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.25e-06	5.71e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—PTPN11—peripheral nervous system neoplasm	7.15e-06	5.63e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—NRAS—peripheral nervous system neoplasm	7.1e-06	5.59e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	7.09e-06	5.58e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—NRAS—peripheral nervous system neoplasm	7e-06	5.51e-05	CbGpPWpGaD
Adenosine triphosphate—ASS1—Metabolism—AKT1—peripheral nervous system neoplasm	6.96e-06	5.48e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.94e-06	5.47e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	6.81e-06	5.36e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—NRAS—peripheral nervous system neoplasm	6.8e-06	5.36e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PTPN11—peripheral nervous system neoplasm	6.78e-06	5.34e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.71e-06	5.28e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.65e-06	5.24e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PTPN11—peripheral nervous system neoplasm	6.6e-06	5.2e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—NRAS—peripheral nervous system neoplasm	6.55e-06	5.16e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.54e-06	5.15e-05	CbGpPWpGaD
Adenosine triphosphate—ADK—Metabolism—AKT1—peripheral nervous system neoplasm	6.47e-06	5.09e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—NRAS—peripheral nervous system neoplasm	6.28e-06	4.94e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—TP53—peripheral nervous system neoplasm	6.27e-06	4.94e-05	CbGpPWpGaD
Adenosine triphosphate—ACSL1—Metabolism—AKT1—peripheral nervous system neoplasm	6.26e-06	4.93e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Metabolism—AKT1—peripheral nervous system neoplasm	6.26e-06	4.93e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—HRAS—peripheral nervous system neoplasm	6.11e-06	4.81e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—MYC—peripheral nervous system neoplasm	6.1e-06	4.8e-05	CbGpPWpGaD
Adenosine triphosphate—ASNS—Metabolism—AKT1—peripheral nervous system neoplasm	6.08e-06	4.79e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.03e-06	4.75e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—HRAS—peripheral nervous system neoplasm	6e-06	4.72e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—TP53—peripheral nervous system neoplasm	5.95e-06	4.68e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.94e-06	4.68e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—MYC—peripheral nervous system neoplasm	5.85e-06	4.61e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.8e-06	4.56e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.78e-06	4.55e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—HRAS—peripheral nervous system neoplasm	5.69e-06	4.48e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.68e-06	4.47e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—ERBB2—peripheral nervous system neoplasm	5.65e-06	4.45e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	5.59e-06	4.4e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.52e-06	4.35e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.47e-06	4.31e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.45e-06	4.29e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—HRAS—peripheral nervous system neoplasm	5.4e-06	4.25e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—ERBB2—peripheral nervous system neoplasm	5.36e-06	4.22e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.3e-06	4.17e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.25e-06	4.13e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—ERBB2—peripheral nervous system neoplasm	5.22e-06	4.11e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—HRAS—peripheral nervous system neoplasm	5.19e-06	4.09e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	5.19e-06	4.08e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—HRAS—peripheral nervous system neoplasm	5.12e-06	4.03e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.12e-06	4.03e-05	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Metabolism—AKT1—peripheral nervous system neoplasm	5.03e-06	3.96e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—AKT1—peripheral nervous system neoplasm	5.02e-06	3.95e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.02e-06	3.95e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	5.02e-06	3.95e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.98e-06	3.92e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—HRAS—peripheral nervous system neoplasm	4.98e-06	3.92e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.81e-06	3.79e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—HRAS—peripheral nervous system neoplasm	4.79e-06	3.77e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.72e-06	3.72e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.71e-06	3.7e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.64e-06	3.65e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.62e-06	3.64e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—HRAS—peripheral nervous system neoplasm	4.6e-06	3.62e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.59e-06	3.61e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—AKT1—peripheral nervous system neoplasm	4.58e-06	3.61e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—AKT1—peripheral nervous system neoplasm	4.52e-06	3.56e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.4e-06	3.46e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—AKT1—peripheral nervous system neoplasm	4.39e-06	3.46e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—NRAS—peripheral nervous system neoplasm	4.3e-06	3.38e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.27e-06	3.36e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	4.24e-06	3.34e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—AKT1—peripheral nervous system neoplasm	4.23e-06	3.33e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.1e-06	3.23e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—NRAS—peripheral nervous system neoplasm	4.08e-06	3.21e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—AKT1—peripheral nervous system neoplasm	4.06e-06	3.19e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.04e-06	3.18e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	3.98e-06	3.14e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—MYC—peripheral nervous system neoplasm	3.98e-06	3.13e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—NRAS—peripheral nervous system neoplasm	3.97e-06	3.12e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.81e-06	3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MYC—peripheral nervous system neoplasm	3.7e-06	2.91e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.65e-06	2.88e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.64e-06	2.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.51e-06	2.76e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.44e-06	2.71e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—AKT1—peripheral nervous system neoplasm	3.4e-06	2.67e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.36e-06	2.65e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.36e-06	2.64e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.32e-06	2.61e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	3.25e-06	2.56e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.22e-06	2.53e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.22e-06	2.53e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HRAS—peripheral nervous system neoplasm	3.15e-06	2.48e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—AKT1—peripheral nervous system neoplasm	3.11e-06	2.45e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HRAS—peripheral nervous system neoplasm	2.98e-06	2.35e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.96e-06	2.33e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—HRAS—peripheral nervous system neoplasm	2.9e-06	2.29e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.84e-06	2.24e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.78e-06	2.19e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—AKT1—peripheral nervous system neoplasm	2.63e-06	2.07e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.59e-06	2.04e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	2.46e-06	1.93e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.13e-06	1.67e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.03e-06	1.6e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	8.78e-07	6.91e-06	CbGpPWpGaD
